Qin L Y, Chen Y, Hou L L, Jin Y H, Lu Y F, Zhang K, Wang M S
Department of Clinical Laboratory, Key Laboratory of Clinical Laboratory Diagnosis and Translational Research of Zhejiang Province, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325015, China.
Department of Hematology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325015, China.
Zhonghua Xue Ye Xue Za Zhi. 2024 Dec 14;45(12):1119-1124. doi: 10.3760/cma.j.cn121090-20240424-00161-1.
This study aimed to primarily discuss the pathogenesis of hereditary coagulation factor Ⅴ (FⅤ) deficiency in a family with a consanguineous cousin marriage. The coagulation indices of the pedigree (three generations with seven individuals) and the thrombin levels of the proband and his father were assessed. All exons of the F5 gene were analyzed with Sanger sequencing, and a new mutation was confirmed with reverse sequencing. The corresponding sites of the family members were then determined. A set of online software was utilized to predict the conservation and pathogenicity of the mutation site. The pathogenicity of this mutation site was evaluated according to the American College of Medical Genetics and Genomics (ACMG) guidelines. The prothrombin time (PT) and activated partial thromboplastin time (APTT) of the proband were 52.2 s and 108.3 s, respectively. FⅤ activity (FⅤ∶ C) and FⅤ antigen (FⅤ∶Ag) were greatly decreased by 2% and 4%, respectively. The problem was diagnosed as type Ⅰ F Ⅴ deficiency. PT and APTT of the proband's father, mother, and grandfather were slightly higher than the upper limit of the reference range, and FⅤ∶C and FⅤ∶Ag were approximately 50% of normal. The thromboplastin generation assay revealed that the amount of thromboplastin produced by the proband and his father was lower than that of the healthy controls and that the proband's ability to produce thromboplastin was more severely impaired. Sequencing analysis revealed that the proband demonstrated a homozygous missense mutation of c.5128T > C (p.Trp1682Arg) in exon 15 of the F5 gene. The grandfather, father, and mother of the proband were all heterozygous for c.5128 T > C. Conservative analysis revealed that p.Trp1682 was a highly conserved site in the homozygous species, and five online software programs, including Mutation Taster, SIFT, REVEL, PolyPhen-2, and CADD, indicated that the mutation was pathogenic. The ACMG guidelines recommend that the new mutation c.5128 T > C is a possible pathogenic mutation (PM2 + PM3 + PP1 + PP3 + PP4). The comparison of the protein models before and after the mutation revealed that the benzene ring and the hydrogen bond were reduced after the mutation, which changed the local structure of the F Ⅴ protein. The missense mutation c.5128T > C (p. Trp1682Arg) in exon 15 of the F5 gene was initially considered the genetic cause of the FⅤ deficiency family. This mutation is the first report globally, which further enriches the gene-phenotype spectrum of FⅤ deficiency.
本研究旨在主要探讨一个近亲表亲结婚家庭中遗传性凝血因子Ⅴ(FⅤ)缺乏症的发病机制。评估了该家系(三代七人)的凝血指标以及先证者及其父亲的凝血酶水平。采用桑格测序法分析F5基因的所有外显子,并用反向测序法确认了一个新突变。然后确定家庭成员的相应位点。利用一套在线软件预测突变位点的保守性和致病性。根据美国医学遗传学与基因组学学会(ACMG)指南评估该突变位点的致病性。先证者的凝血酶原时间(PT)和活化部分凝血活酶时间(APTT)分别为52.2秒和108.3秒。FⅤ活性(FⅤ∶C)和FⅤ抗原(FⅤ∶Ag)分别大幅下降至2%和4%。该问题被诊断为Ⅰ型FⅤ缺乏症。先证者的父亲、母亲和祖父的PT和APTT略高于参考范围上限,FⅤ∶C和FⅤ∶Ag约为正常水平的50%。凝血活酶生成试验显示,先证者及其父亲产生的凝血活酶量低于健康对照者,且先证者产生凝血活酶的能力受损更严重。测序分析显示,先证者在F5基因第15外显子中存在c.5128T>C(p.Trp1682Arg)的纯合错义突变。先证者的祖父、父亲和母亲均为c.5128T>C杂合子。保守性分析显示,p.Trp1682在纯合物种中是一个高度保守的位点,包括Mutation Taster、SIFT、REVEL、PolyPhen - 2和CADD在内的五个在线软件程序表明该突变具有致病性。ACMG指南建议,新突变c.5128T>C是一个可能的致病性突变(PM2 + PM3 + PP1 + PP3 + PP4)。突变前后蛋白质模型的比较显示,突变后苯环和氢键减少,这改变了FⅤ蛋白的局部结构。F5基因第15外显子中的错义突变c.5128T>C(p.Trp1682Arg)最初被认为是该FⅤ缺乏症家系的遗传病因。该突变是全球首例报道,进一步丰富了FⅤ缺乏症的基因 - 表型谱。